3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
- 24 March 1999
- journal article
- review article
- Published by Elsevier BV in Neuroscience & Biobehavioral Reviews
- Vol. 23 (4), 539-553
- https://doi.org/10.1016/s0149-7634(98)00046-3
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Hydroxyl Radical‐Mediated Oxidation of Serotonin: Potential Insights into the Neurotoxicity of MethamphetamineJournal of Neurochemistry, 1995
- Aplastic anaemia following exposure to 3,4‐methylenedioxymethamphetamine (‘Ecstasy’)British Journal of Haematology, 1994
- Increasing Use of “Ecstasy“ (MDMA) and other Hallucinogens on a College CampusJournal of American College Health, 1994
- Exertional heat stroke induced by amphetamine analoguesAnaesthesia, 1993
- Ecstasy and dantrolene.BMJ, 1993
- Accidental ingestion of 'Ecstasy' (3,4-methylenedioxymethylamphetamine).Archives of Disease in Childhood, 1992
- Methamphetamine-induced Neurotoxicity: Structure Activity RelationshipsAnnals of the New York Academy of Sciences, 1992
- Chronic paranoid psychosis after misuse of MDMA.BMJ, 1991
- Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate CampusNew England Journal of Medicine, 1987
- Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacologyArchives of Internal Medicine, 1981